Back

The effect of virtual reality on anxiety reduction in supraventricular tachycardia ablation: prospective study

1 April 2025 (13:30 - 14:15)
Organised by: Logo
Congress Presentation Part of: Miscellaneous aspects in arrhythmias care Treatment EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Assistant Professor Yigit Yilancioglu

Dokuz Eylul University, Izmir (Turkiye)

6 More presentations in this session

Presentation thumbnail
Management of rhythm and conduction disorders in cardiac amyloidosis: a French nationwide Delphi study
Professor C. Guenancia (Dijon, FR)
Abstract Slides Video
Presentation thumbnail
The many NO's to the use of class I antiarrhythmics: does this also apply to ethacizinum?
Doctor E. Sokolova (Riga, LV)
Abstract Slides Video
Presentation thumbnail
Physician workload related to ILR false alarms in the era of telemedicine
Doctor L. Cocchiara (Naples, IT)
Abstract Slides Video
Presentation thumbnail
Digital health in the EP lab: evaluating the safety and feasibility of routine implementation of remote access and technical support in complex ablation procedures - results of the REMOTE study
Doctor S. Popescu (Luebeck, DE) Doctor B. Botezat (Luebeck, DE)
Abstract Slides Video
Presentation thumbnail
Arrhythmogenic effects and cardioprotective effects of dapagliflozin against radiotherapy induced cardiac damage
Doctor M. Uzun (Kutahya, TR) Miss S. Ulusan (Isparta, TR)
Abstract Slides Video

Access the full session

Session thumbnail
Miscellaneous aspects in arrhythmias care

The Event

Event poster

EHRA 2025

1 April 2025 13:30 CET
You may be interested in
thumbnail
Congress Presentation
Optimizing conscious sedation and anxiety control using virtual reality in the electrophysiology lab: a retrospective pilot study on VT ablation
thumbnail
Congress Presentation
The effectiveness of virtual reality on cardiac procedure related anxiety: a systematic review and meta-analysis
thumbnail
Congress Presentation
Impact of virtual reality distraction on stress and pain reduction during implantation of cardiac pacemakers, defibrillators or cardiac resynchronisation therapy, a randomised controlled study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources